Absolutely. The money comes back to the Department of Health and is invested in the NHS. Indeed, it would be wonderful if it was more than £1.24 billion, because there is an awful lot of need on the NHS frontline right now; the funds are much needed. Our concern is that companies have been exploiting the differences between the voluntary and statutory schemes, particularly the loophole, which the Bill seeks to close, that if companies have drugs in both schemes, we are unable to regulate at all the prices of the drugs that would ordinarily fall under the statutory scheme. That is why the Bill is so important.
Health Service Medical Supplies (Costs) Bill
Proceeding contribution from
Jeremy Hunt
(Conservative)
in the House of Commons on Monday, 24 October 2016.
It occurred during Debate on bills on Health Service Medical Supplies (Costs) Bill.
About this proceeding contribution
Reference
616 c75 Session
2016-17Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2020-04-14 16:59:28 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2016-10-24/16102429000023
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2016-10-24/16102429000023
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2016-10-24/16102429000023